BMC Neurol

1. MU H, Ji F, Du R, Hou L, et al
   Polycythemia vera and stiff-person syndrome: a case report.
   BMC Neurol. 2026;26:122.
   

   >> Share

   
   
2. ISHIKAWA K, Horiuchi K, Saika S, Nakamura S, et al
   A case report of neurosarcoidosis mimicking Guillain-Barre syndrome: the diagnostic utility of skin biopsy in neurosarcoidosis.
   BMC Neurol. 2026 Feb 19. doi: 10.1186/s12883-026-04753.
   

   >> Share

   
   
3. TAN H, Zhou L, Gao Y, Zhao C, et al
   Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.
   BMC Neurol. 2026 Feb 18. doi: 10.1186/s12883-026-04727.
   

   >> Share

   
   
4. FU J, Zheng X, Ma X, Qu Q, et al
   Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod.
   BMC Neurol. 2026 Feb 16. doi: 10.1186/s12883-026-04726.
   

   >> Share

   
   

   
   Diabetes

5. GREENBAUM CJ, Long SA, Gitelman SE, Gaglia JL, et al
   Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
   Diabetes. 2026 Jan 21:db250777. doi: 10.2337/db25-0777.
   

   >> Share

   
   

   
   Intern Med

6. MINEKAWA E, Oto Y, Muro Y, Nishino I, et al
   Acute muscle injury and subcutaneous edema in a patient with anti-nuclear matrix protein-2 antibody positive dermatomyositis sine dermatitis: A Case Report.
   Intern Med. 2026 Feb 17. doi: 10.2169/internalmedicine.6410.
   

   >> Share

   
   

   
   J Autoimmun

7. VAN GOMPEL E, Galesic M, Delaroque N, Kern K, et al
   Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.
   J Autoimmun. 2026;159:103536.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

8. WEI M, Mehravar S, Leite G, Naji P, et al
   Relationship between hypothyroidism, risk of small intestinal bacterial overgrowth, and duodenal microbiome alterations.
   J Clin Endocrinol Metab. 2025 Sep 5:dgaf495. doi: 10.1210.
   

   >> Share

   
   

   
   J Neurol

9. GUO J, Olsson T, Alfredsson L, Hedstrom AK, et al
   Disability progression in multiple sclerosis: a latent class analysis of predictors.
   J Neurol. 2026;273:157.
   

   >> Share

   
   
10. LIN J, Chang T, Xiao L, Hu J, et al
    Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.
    J Neurol. 2026;273:146.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

11. CAMBAZ KURT N, Kocabey Sutcu Z, Sener G, Onal H, et al
    Evaluation of adrenomedullin levels in adolescents with Hashimoto's thyroiditis: association with clinical and laboratory findings.
    J Pediatr Endocrinol Metab. 2026 Feb 10. doi: 10.1515/jpem-2025-0515.
    

    >> Share

    
    
12. BAIOUMI A, Darma K, Selvarajan L, Hamblin R, et al
    Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.
    J Pediatr Endocrinol Metab. 2026 Feb 20. doi: 10.1515/jpem-2025-0522.
    

    >> Share

    
    
13. DAYAL D, Raha SJ, Banerjee S, Bala A, et al
    Cataract in children with type 1 diabetes: a single-center experience from North India on an underrecognized complication.
    J Pediatr Endocrinol Metab. 2025;39:173-177.
    

    >> Share

    
    
14. GONZALEZ F, Reid MW, Garcia JF, Raymond JK, et al
    GLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study.
    J Pediatr Endocrinol Metab. 2025;39:166-172.
    

    >> Share

    
    
15. ALASSAF A, Gharaibeh L, Ibrahim S, Alkhalaileh S, et al
    Knowledge of advanced carbohydrate counting in children and adolescents with type 1 diabetes and its effect on glycaemic control.
    J Pediatr Endocrinol Metab. 2025;39:178-187.
    

    >> Share

    
    

    
    Mult Scler

16. MILLER A, Cohen JA, Karni A, Popper L, et al
    GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.
    Mult Scler. 2026;32:202-213.
    

    >> Share

    
    
17. PATEL MA, Punnen TG, Shan KS, McCreary MC, et al
    Clinical and radiological outcomes of directed treatment transitions from Gilenya((R)) to generic fingolimod.
    Mult Scler. 2026;32:192-201.
    

    >> Share

    
    
18. COMET C, Jouvenot G, Bourre B, Ciron J, et al
    Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients.
    Mult Scler. 2026;32:214-223.
    

    >> Share

    
    
19. SHINODA K, Masaki K, Matsuyoshi A, Kira YI, et al
    Tumefactive demyelinating lesion during B-cell depletion therapy by ofatumumab.
    Mult Scler. 2026;32:244-247.
    

    >> Share

    
    
20. SIAVOSHI F, Noroozi R, Chang G, Schoeps VA, et al
    Accelerated metabolomic aging and its association with social determinants of health in multiple sclerosis.
    Mult Scler. 2026 Feb 20:13524585261417120. doi: 10.1177/13524585261417120.
    

    >> Share

    
    

    
    Neurol Clin Pract

21. HARTUNG DM, Gabriel N, Gellad WF, Cameron T, et al
    Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021.
    Neurol Clin Pract. 2026;16:e200597.
    

    >> Share

    
    

    
    Neurology

22. CHANDRA A, Acharya S, Chandra A
    Global & Community Health: Diagnosis and Management of Multiple Sclerosis in Nepal: Overcoming Barriers Through Local Adaptations.
    Neurology. 2026;106:e214743.
    

    >> Share

    
    

    
    PLoS One

23. DENG Q, Bai Q, Yang Y, Tang W, et al
    A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability.
    PLoS One. 2026;21:e0341867.
    

    >> Share

    
    
24. AKBARI H, Ragerdi-Kashani I, Rezaei-Yazdi F, Pasbakhsh P, et al
    Effect of transplanted oligodendrocyte precursor cells derived from inflammatory and non-inflammatory microenvironment on remyelination in a chronic cuprizone model.
    PLoS One. 2026;21:e0343039.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

25. SARRAZIN N, Arab R, Cordano C, Brazhnikova E, et al
    Clemastine fumarate promotes myelin repair in a nonhuman primate model of demyelination characterized by absent spontaneous remyelination.
    Proc Natl Acad Sci U S A. 2026;123:e2520161123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share